Cefoxitin Sodium for Injection

See instructions for details.

The main ingredient of this product is ceftriaxone sodium.

This product is white or off-white powder with strong hygroscopicity.

1. This product is suitable for the following infections caused by bacteria sensitive to this product: upper and lower respiratory tract infections, urinary tract infections including uncomplicated gonorrhea, peritonitis and other intra-abdominal and pelvic infections, sepsis (including typhoid fever), gynecological infections, bone and joint soft tissue infections, endocarditis. 2. Since this product is effective against anaerobic bacteria and stable to β-lactamase, it is particularly suitable for mixed aerobic and anaerobic infections, as well as infections caused by bacteria that produce β-lactamase and are sensitive to this product.

Intramuscular injection, intravenous injection or intravenous drip

This product has mild adverse reactions. The most common local reactions: thrombophlebitis may occur after intravenous injection, and local induration and tenderness may occur after intramuscular injection. In addition, allergic reactions (rash, itching, eosinophilia, fever, dyspnea, etc.), hypotension, diarrhea, nausea, vomiting, leukopenia, thrombocytopenia, anemia, and transient increases in ALT, AST, ALP, LDH, BUN or serum Cr values are occasionally seen.

Patients who are allergic to this product and cephalosporin antibiotics are contraindicated.

Precautions for children: The effectiveness and safety of this product for newborns to 3 months old have not been established. For children 3 months old and older, large doses of this product can lead to eosinophilia and elevated SGOT. Precautions for pregnancy and lactation: This product can enter the fetal blood circulation through the placenta, so pregnant women should use it with caution. This product can be secreted into breast milk at low concentrations, so breastfeeding women should weigh the pros and cons when using this product. Precautions for the elderly: Clinical studies and clinical reports have not found significant differences in safety and effectiveness between the elderly and young people, but it cannot be ruled out that the elderly individuals have a higher sensitivity.

1. Cefoxitin sodium has a synergistic antibacterial effect when used in combination with aminoglycoside antibiotics, but the combination will increase nephrotoxicity. 2. Cefoxitin sodium can increase nephrotoxicity when used in combination with strong diuretics such as furosemide. 3. Cefoxitin sodium can delay the excretion of the drug when used in combination with probenecid, increase the blood concentration of cefoxitin and prolong its half-life. 4. Cefoxitin sodium can affect alcohol metabolism, increase the concentration of acetaldehyde in the blood, and lead to disulfiram-like reactions (facial flushing, headache, dizziness, abdominal pain, stomach pain, nausea, vomiting, shortness of breath, increased heart rate, decreased blood pressure, drowsiness, hallucinations, etc.)

cool

0.5g*10 bottles/box

ShenZhen Lijian Pharmaceutical Co., Ltd.

• Founded in:

  2001-04-28

• Address:

  1st Floor, Building B2, No. 1 Yuanfu Road, Shanghenglang Community, Dalang Street, Longhua District, Shenzhen

• Tax NO.:

  91440300728555703C

• Registered Funds:

  40 million yuan

• Website:

  Log in to view

• Email:

  Log in to view